T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2012-07-11EMA Refused: Folotyn (pralatrexate) — Allos Therapeutics Ltd
EMA refused approval for Folotyn (pralatrexate) by Allos Therapeutics Ltd for T-cell lymphoma indications.